Barely Significant
← all excerpts

Whole-Genome Sequencing Identifies <i>PPARGC1A</i> as a Putative Modifier of Cancer Risk in <i>BRCA1/2</i> Mutation Carriers.

Cancers (Basel) · 2022 · PMC9139302 · PMID 35625955

Europe PMCDOI
1
hedged sentence
0.0550
closest p · 1.1× alpha
0.0550
boldest claim

The sentences

borderline significancep = 0.055so close (0.05 < p ≤ 0.1)
When combining the discovery and validation cohorts, the PPARGC1A gene in BRCA carriers possessed more deleterious mutations than in non-carriers with borderline significance ( p = 0.055, Figure 3 b).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.